Neutralization of SARS‐CoV‐2 requires antibodies against conformational receptor‐binding domain epitopes.

MLA

Gattinger, Pia, et al. “Neutralization of SARS‐CoV‐2 Requires Antibodies against Conformational Receptor‐binding Domain Epitopes.” Allergy, vol. 77, no. 1, Jan. 2022, pp. 230–42. EBSCOhost, https://doi.org/10.1111/all.15066.

APA

Gattinger, P., Niespodziana, K., Stiasny, K., Sahanic, S., Tulaeva, I., Borochova, K., Dorofeeva, Y., Schlederer, T., Sonnweber, T., Hofer, G., Kiss, R., Kratzer, B., Trapin, D., Tauber, P. A., Rottal, A., Körmöczi, U., Feichter, M., Weber, M., Focke, T. M., & Löffler, R. J. (2022). Neutralization of SARS‐CoV‐2 requires antibodies against conformational receptor‐binding domain epitopes. Allergy, 77(1), 230–242. https://doi.org/10.1111/all.15066

Chicago

Gattinger, Pia, Katarzyna Niespodziana, Karin Stiasny, Sabina Sahanic, Inna Tulaeva, Kristina Borochova, Yulia Dorofeeva, et al. 2022. “Neutralization of SARS‐CoV‐2 Requires Antibodies against Conformational Receptor‐binding Domain Epitopes.” Allergy 77 (1): 230–42. doi:10.1111/all.15066.